Curi RMB Capital LLC Has $12.92 Million Position in Kenvue Inc. (NYSE:KVUE)

Curi RMB Capital LLC cut its holdings in Kenvue Inc. (NYSE:KVUE) by 48.7% in the 3rd quarter, Holdings Channel.com reports. The firm owned 558,482 shares of the company’s stock after selling 530,315 shares during the quarter. Curi RMB Capital LLC’s holdings in Kenvue were worth $12,918,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of KVUE. SAM Advisors LLC boosted its holdings in shares of Kenvue by 2.5% in the third quarter. SAM Advisors LLC now owns 52,459 shares of the company’s stock valued at $1,213,000 after buying an additional 1,274 shares during the period. Huntington National Bank lifted its position in Kenvue by 26.5% in the 3rd quarter. Huntington National Bank now owns 4,161 shares of the company’s stock valued at $96,000 after acquiring an additional 871 shares in the last quarter. KBC Group NV boosted its stake in Kenvue by 114.0% in the 3rd quarter. KBC Group NV now owns 966,160 shares of the company’s stock worth $22,348,000 after purchasing an additional 514,580 shares during the period. ICICI Prudential Asset Management Co Ltd increased its holdings in Kenvue by 4.0% during the 3rd quarter. ICICI Prudential Asset Management Co Ltd now owns 423,060 shares of the company’s stock worth $9,785,000 after purchasing an additional 16,460 shares in the last quarter. Finally, Saturna Capital Corp raised its stake in shares of Kenvue by 29.9% in the 3rd quarter. Saturna Capital Corp now owns 1,334,860 shares of the company’s stock valued at $30,875,000 after purchasing an additional 307,039 shares during the period. 97.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on KVUE shares. UBS Group raised their price target on shares of Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 7th. JPMorgan Chase & Co. lifted their price target on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Royal Bank of Canada downgraded shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price objective for the company. in a research note on Tuesday, September 24th. Bank of America lifted their target price on Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Tuesday, October 22nd. Finally, Jefferies Financial Group initiated coverage on Kenvue in a research report on Tuesday, September 24th. They set a “buy” rating and a $27.00 price target for the company. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $22.64.

Kenvue Stock Performance

Shares of NYSE KVUE opened at $23.13 on Thursday. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $44.35 billion, a P/E ratio of 42.05, a P/E/G ratio of 2.15 and a beta of 1.36. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $23.95. The stock has a 50 day moving average of $22.72 and a 200-day moving average of $20.62.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. The company had revenue of $3.90 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The business’s revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.31 earnings per share. As a group, equities research analysts predict that Kenvue Inc. will post 1.07 EPS for the current year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th will be issued a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.55%. The ex-dividend date is Wednesday, November 13th. Kenvue’s dividend payout ratio is currently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.